These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7779060)

  • 41. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.
    Pagano D; Bonser RS; Townend JN; Ordoubadi F; Lorenzoni R; Camici PG
    Heart; 1998 Mar; 79(3):281-8. PubMed ID: 9602663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction.
    Paolini G; Lucignani G; Zuccari M; Landoni C; Vanoli G; Di Credico G; Rossetti C; Mariani MA; Fazio F; Grossi A
    Eur J Cardiothorac Surg; 1994; 8(3):139-44. PubMed ID: 8011347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Speckle tracking echocardiography derived systolic longitudinal strain is better than rest single photon emission tomography perfusion imaging for nonviable myocardium identification.
    Hutyra M; Skala T; Kaminek M; Horak D; Kocher M; Tudos Z; Jarkovsky J; Precek J; Taborsky M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):12-21. PubMed ID: 23073534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging to distinguish between viable and nonviable myocardium: pathophysiologic basis and importance of positron emission tomography.
    Gropler RJ
    AJR Am J Roentgenol; 1993 Sep; 161(3):497-500. PubMed ID: 8352093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The complex relation between myocardial viability and functional recovery in chronic left ventricular dysfunction.
    Agati L; Autore C; Iacoboni C; Castaldo M; Veneroso G; Voci P; Fedele F; Dagianti A
    Am J Cardiol; 1998 Jun; 81(12A):33G-35G. PubMed ID: 9662225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of myocardial viability in chronic left ventricular dysfunction.
    Ling LH; Tei C; Pellikka PA
    J Cardiol; 1995 Apr; 25(4):199-211. PubMed ID: 7752054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].
    Baer FM; Theissen P; Schneider CA; Voth E; Schicha H; Sechtem U
    Herz; 1994 Feb; 19(1):51-64. PubMed ID: 8150414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Importance of ischemic and viable myocardium for patients with chronic ischemic mitral regurgitation and left ventricular dysfunction.
    Pu M; Thomas JD; Gillinov MA; Griffin BP; Brunken RC
    Am J Cardiol; 2003 Oct; 92(7):862-4. PubMed ID: 14516895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Frank JA; Bonow RO
    Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Off-pump coronary artery bypass surgery outcomes in patients with ischaemic left ventricular systolic dysfunction with or without detected viable myocardium.
    Li S; Li H; Yuan Z; Zhang B; Chen A; Zhou M; Liu J; Cai J; Wang Z; Ye X; Zhao Q
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):218-224. PubMed ID: 28475697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Assessing the informative value of positron emission tomography with the new radiopharmaceutical Sodium 11C-butyrate versus small-dose dobutamine stress echocardiography in the diagnosis of myocardial viability in patients with coronary heart disease and left ventricular dysfunction].
    Ryzhkova D; Tiutin L; Kostenikov N; Nifontov E; Shliakhto E; Savello V; Rudomanov O; Zakharov D; Kazarin V
    Vestn Rentgenol Radiol; 2001; (4):4-9. PubMed ID: 11603328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged ischemic heart disease and coronary artery bypass - relation to contractile reserve.
    Kofoed KF; Bangsgaard R; Carstensen S; Svendsen JH; Hansen PR; Arendrup H; Hesse B; Kelbaek H
    Eur J Cardiothorac Surg; 2002 Mar; 21(3):417-23. PubMed ID: 11888757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.
    Tajouri TH; Chareonthaitawee P
    Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):55-63. PubMed ID: 20014935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease.
    Patterson RE; Pilcher WC
    Semin Thorac Cardiovasc Surg; 1995 Oct; 7(4):214-26. PubMed ID: 8590746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial stunning and hibernation.
    Rinaldi CA; Hall RJ
    Indian Heart J; 1996; 48(6):721-5. PubMed ID: 9062030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The noninvasive assessment of myocardial viability.
    Ragosta M; Beller GA
    Clin Cardiol; 1993 Jul; 16(7):531-8. PubMed ID: 8348761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does the presence of hibernating myocardium in patients with impaired left ventricular contraction affect QT dispersion?
    Al Mohammad A; Mahy IR; Buckley A; Cargill RI; Norton MY; Welch AE; Walton S
    Am Heart J; 2001 Jun; 141(6):944-8. PubMed ID: 11376308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of positron emission tomography with the resting electrocardiogram for assessing viable myocardium in chronic ischemic cardiomyopathy involving the anterior left ventricular wall.
    Desideri A; Zanco P; Bertella M; Bigi R; Cortigiani L; Bax J; Suzzi G; Celegon L
    Am J Cardiol; 2002 Oct; 90(8):878-82. PubMed ID: 12372579
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions.
    Di Carli MF; Maddahi J; Rokhsar S; Schelbert HR; Bianco-Batlles D; Brunken RC; Fromm B
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):997-1004. PubMed ID: 9832692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction.
    Sicari R; Ripoli A; Picano E; Borges AC; Varga A; Mathias W; Cortigiani L; Bigi R; Heyman J; Polimeno S; Silvestri O; Gimenez V; Caso P; Severino S; Djordjevic-Dikic A; Ostojic M; Baldi C; Seveso G; Petix N;
    Eur Heart J; 2001 May; 22(10):837-44. PubMed ID: 11409375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.